148 related articles for article (PubMed ID: 11053628)
1. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.
van den Elsen PJ; van der Stoep N; Viëtor HE; Wilson L; van Zutphen M; Gobin SJ
Hum Immunol; 2000 Sep; 61(9):850-62. PubMed ID: 11053628
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional control of MHC genes in fetal trophoblast cells.
van den Elsen PJ; Gobin SJ; van der Stoep N; Datema G; Viëtor HE
J Reprod Immunol; 2001; 52(1-2):129-45. PubMed ID: 11600183
[TBL] [Abstract][Full Text] [Related]
3. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
[TBL] [Abstract][Full Text] [Related]
4. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
Murphy SP; Tomasi TB
Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
[TBL] [Abstract][Full Text] [Related]
5. Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
van der Stoep N; Biesta P; Quinten E; van den Elsen PJ
Int J Cancer; 2002 Feb; 97(4):501-7. PubMed ID: 11802213
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
[TBL] [Abstract][Full Text] [Related]
7. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
[TBL] [Abstract][Full Text] [Related]
8. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression.
Morris AC; Riley JL; Fleming WH; Boss JM
Am J Reprod Immunol; 1998 Dec; 40(6):385-94. PubMed ID: 9894561
[TBL] [Abstract][Full Text] [Related]
9. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract][Full Text] [Related]
10. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
[TBL] [Abstract][Full Text] [Related]
11. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
12. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
13. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
[TBL] [Abstract][Full Text] [Related]
14. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.
Morris AC; Spangler WE; Boss JM
J Immunol; 2000 Apr; 164(8):4143-9. PubMed ID: 10754309
[TBL] [Abstract][Full Text] [Related]
15. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
Kanaseki T; Ikeda H; Takamura Y; Toyota M; Hirohashi Y; Tokino T; Himi T; Sato N
J Immunol; 2003 May; 170(10):4980-5. PubMed ID: 12734341
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.
Morris AC; Beresford GW; Mooney MR; Boss JM
Mol Cell Biol; 2002 Jul; 22(13):4781-91. PubMed ID: 12052885
[TBL] [Abstract][Full Text] [Related]
18. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
Rahat MA; Chernichovski I; Lahat N
Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA.
Lefebvre S; Moreau P; Dausset J; Carosella ED; Paul P
Placenta; 1999 May; 20(4):293-301. PubMed ID: 10329350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
